Page last updated: 2024-08-24

imiquimod and isotretinoin

imiquimod has been researched along with isotretinoin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Jurado-Santa Cruz, F; Morales-Sánchez, MA; Olguin-García, MG; Peralta-Pedrero, ML1
De la Torre Gomar, FJ; Gimeno Castillo, J; Saenz Aguirre, A1

Trials

1 trial(s) available for imiquimod and isotretinoin

ArticleYear
A double-blind, randomized, placebo-controlled trial of oral isotretinoin in the treatment of recalcitrant facial flat warts.
    The Journal of dermatological treatment, 2015, Volume: 26, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Aminoquinolines; Cryotherapy; Dermatologic Agents; Double-Blind Method; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Isotretinoin; Male; Treatment Outcome; Warts; Young Adult

2015

Other Studies

2 other study(ies) available for imiquimod and isotretinoin

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Extensive condyloma acuminata: Complete remission after oral isotretinoin and topical imiquimod. A successful combination?
    Dermatologic therapy, 2022, Volume: 35, Issue:7

    Topics: Administration, Topical; Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Isotretinoin; Remission Induction

2022